GlaxoSmithKline

Results: 1417



#Item
941GINA 2014 Global Strategy for Asthma Management and Prevention and Online Appendix 2014 Correction to wording about fluticasone furoate/vilanterol In the GINA 2014 strategy report, fluticasone furoate/vilanterol was incl

GINA 2014 Global Strategy for Asthma Management and Prevention and Online Appendix 2014 Correction to wording about fluticasone furoate/vilanterol In the GINA 2014 strategy report, fluticasone furoate/vilanterol was incl

Add to Reading List

Source URL: www.ginasthma.org

Language: English
942Untitled Document  This content was archived on June 24, 2013. Archived Content Information identified as archived on the Web is for reference, research or recordkeeping purposes. It

Untitled Document This content was archived on June 24, 2013. Archived Content Information identified as archived on the Web is for reference, research or recordkeeping purposes. It

Add to Reading List

Source URL: hc-sc.gc.ca

Language: English - Date: 2013-06-24 13:31:41
943Benjamin Presentation Panel 4, June 24-25, 2010

Benjamin Presentation Panel 4, June 24-25, 2010

Add to Reading List

Source URL: www.fda.gov

Language: English
944NEW EXCEPTION DRUG STATUS LISTINGS:

NEW EXCEPTION DRUG STATUS LISTINGS:

Add to Reading List

Source URL: formulary.drugplan.health.gov.sk.ca

Language: English - Date: 2014-06-26 15:57:56
945BC PharmaCare Newsletter[removed]January 25, 2011)

BC PharmaCare Newsletter[removed]January 25, 2011)

Add to Reading List

Source URL: www.health.gov.bc.ca

Language: English - Date: 2014-03-05 12:00:06
946Tennessee, 37 Other State Attorneys General Reach $40.75 Million Agreement With GlaxoSmithKline and SB Pharmco

Tennessee, 37 Other State Attorneys General Reach $40.75 Million Agreement With GlaxoSmithKline and SB Pharmco

Add to Reading List

Source URL: www.tn.gov

Language: English - Date: 2011-07-20 17:31:20
947“GSK Canada Life Sciences Innovation Fund” On November 10, 2011, Paul Lucas, President and CEO, GlaxoSmithKline Inc. (GSK), together with Dr. Moncef Slaoui, Global Chairman of Research and Development at GlaxoSmithKl

“GSK Canada Life Sciences Innovation Fund” On November 10, 2011, Paul Lucas, President and CEO, GlaxoSmithKline Inc. (GSK), together with Dr. Moncef Slaoui, Global Chairman of Research and Development at GlaxoSmithKl

Add to Reading List

Source URL: www.gsk.ca

Language: English - Date: 2012-05-01 15:28:36
948California ADAP Access Form for Rosiglitazone (Avandia®) Use in Type 2 Diabetes TELEPHONE: [removed]FAX: [removed]After considering the available data on the cardiovascular risks of rosiglitazone ((Avandia®) th

California ADAP Access Form for Rosiglitazone (Avandia®) Use in Type 2 Diabetes TELEPHONE: [removed]FAX: [removed]After considering the available data on the cardiovascular risks of rosiglitazone ((Avandia®) th

Add to Reading List

Source URL: www.ramsellcorp.com

Language: English - Date: 2012-04-20 10:50:45
949flonase nasal spray, 50 mcg

flonase nasal spray, 50 mcg

Add to Reading List

Source URL: www.fda.gov

Language: English - Date: 2004-09-14 08:01:31
950Saskatchewan Ministry of Health Drug Plan and Extended Benefits Branch November 1, 2010 Bulletin #126 ISSN 1923-077X

Saskatchewan Ministry of Health Drug Plan and Extended Benefits Branch November 1, 2010 Bulletin #126 ISSN 1923-077X

Add to Reading List

Source URL: formulary.drugplan.health.gov.sk.ca

Language: English - Date: 2014-06-26 15:57:54